1. Home
  2. FOLD vs EMAT Comparison

FOLD vs EMAT Comparison

Compare FOLD & EMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.46

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

EMAT

Evolution Metals & Technologies Corp. Common Stock

N/A

Current Price

$8.11

Market Cap

4.2B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
FOLD
EMAT
Founded
2002
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.2B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
FOLD
EMAT
Price
$14.46
$8.11
Analyst Decision
Buy
Strong Buy
Analyst Count
9
1
Target Price
$27.25
$30.00
AVG Volume (30 Days)
2.6M
88.8K
Earning Date
04-30-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.50
N/A
Revenue Next Year
$18.59
$2,122.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.66
$5.50
52 Week High
$14.48
$17.50

Technical Indicators

Market Signals
Indicator
FOLD
EMAT
Relative Strength Index (RSI) 66.60 50.74
Support Level $14.21 $7.58
Resistance Level N/A $8.62
Average True Range (ATR) 0.02 0.67
MACD -0.01 0.14
Stochastic Oscillator 75.00 74.72

Price Performance

Historical Comparison
FOLD
EMAT

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About EMAT Evolution Metals & Technologies Corp. Common Stock

Evolution Metals & Technologies Corp is a critical materials and technology company. The company is focused on developing a secure, dependable, and self-sustaining U.S.-aligned supply chain for critical minerals and materials (CMM), and rare earth elements (REEs). The company is also engaged in recycling end-of-life materials through urban mining to help strengthen domestic resource independence and long-term supply stability.

Share on Social Networks: